NKGen Biotech, Inc. (NKGN) has 8 open-market insider trades by 4 insiders since 2023. The most active filer is Paul Y. Song, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Paul Y. Song | CEO | — | 5 | $5.4M | 2025-05-05 |
| Andrew Jin-Chan Cherng | 10% Owner | — | 1 | $5.1M | 2025-05-27 |
| James A. Graf | Interim CFO10% | — | 1 | $2K | 2024-12-20 |
| Graf Acquisition Partners IV LLC | 10% | — | 1 | $67 | 2024-12-18 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrew Jin-Chan Cherng | 10% Owner | Buy | $5.1M | 2025-05-27 |
| Paul Y. Song | CEO | Buy | $5.4M | 2025-05-05 |
| Paul Y. Song | CEO | Buy | $500 | 2023-12-06 |
| Paul Y. Song | CEO | Buy | $850 | 2023-12-04 |
| James A. Graf | Interim CFO | Buy | $2K | 2023-12-01 |
| Paul Y. Song | CEO | Buy | $701 | 2023-11-27 |
Companies that share insiders with NKGN, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Paul Y. Song | CEO | Buy | $430 | 2023-11-21 |
| Graf Acquisition Partners IV LLC | 10% | Buy | $67 | 2023-11-20 |